in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
CPhI: Drug product manufacturing business to drive growth for Hovione
7:53 PM MDT | October 9, 2012 | Deepti Ramesh in Madrid
Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) says that it expects the drug product business to be the growth driver for Hovione post 2015, and that this is a significant change for the company. “I think that a lot of the growth that Hovione will enjoy during the second half of this decade will be around the drug product manufacturing business, because it is an area where you need much more sophisticated science and where you have more demanding regulators,” Guy Villax, CEO of Hovione tells CW on the sidelines of a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee